Medical and pharmacologic management of the HIV-infected child

C. Diaz, Caroline J Chantry, R. Yogev

Research output: Contribution to journalArticle

Abstract

Pharmacologic intervention and medical support of the HIV-infected child have to be clearly focused on improving duality of life and decreasing the rate of disease progression. The optimal timing and agents will be defined as we find answers to crucial questions such as: How early to intervene? Should we have a single or multiple agent approach? Answers to these questions are critically needed. Well-designed and conducted clinical trials will shed light and needed data to answer these questions and will allow us to redefine recommendations for the near future.

Original languageEnglish (US)
Pages (from-to)395-420
Number of pages26
JournalImmunology and Allergy Clinics of North America
Volume15
Issue number2
StatePublished - 1995
Externally publishedYes

Fingerprint

Disease Progression
Clinical Trials
HIV

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Medical and pharmacologic management of the HIV-infected child. / Diaz, C.; Chantry, Caroline J; Yogev, R.

In: Immunology and Allergy Clinics of North America, Vol. 15, No. 2, 1995, p. 395-420.

Research output: Contribution to journalArticle

@article{7248a0b4e8ba415f916860866d8c8e73,
title = "Medical and pharmacologic management of the HIV-infected child",
abstract = "Pharmacologic intervention and medical support of the HIV-infected child have to be clearly focused on improving duality of life and decreasing the rate of disease progression. The optimal timing and agents will be defined as we find answers to crucial questions such as: How early to intervene? Should we have a single or multiple agent approach? Answers to these questions are critically needed. Well-designed and conducted clinical trials will shed light and needed data to answer these questions and will allow us to redefine recommendations for the near future.",
author = "C. Diaz and Chantry, {Caroline J} and R. Yogev",
year = "1995",
language = "English (US)",
volume = "15",
pages = "395--420",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Medical and pharmacologic management of the HIV-infected child

AU - Diaz, C.

AU - Chantry, Caroline J

AU - Yogev, R.

PY - 1995

Y1 - 1995

N2 - Pharmacologic intervention and medical support of the HIV-infected child have to be clearly focused on improving duality of life and decreasing the rate of disease progression. The optimal timing and agents will be defined as we find answers to crucial questions such as: How early to intervene? Should we have a single or multiple agent approach? Answers to these questions are critically needed. Well-designed and conducted clinical trials will shed light and needed data to answer these questions and will allow us to redefine recommendations for the near future.

AB - Pharmacologic intervention and medical support of the HIV-infected child have to be clearly focused on improving duality of life and decreasing the rate of disease progression. The optimal timing and agents will be defined as we find answers to crucial questions such as: How early to intervene? Should we have a single or multiple agent approach? Answers to these questions are critically needed. Well-designed and conducted clinical trials will shed light and needed data to answer these questions and will allow us to redefine recommendations for the near future.

UR - http://www.scopus.com/inward/record.url?scp=0029024425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029024425&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 395

EP - 420

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 2

ER -